SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
CONMED Corporation amended and restated its bylaws to allow stockholder meetings via remote communication and establishes 25% ownership threshold for stockholder-requested special …
Telomir Pharmaceuticals announced peer-reviewed publication of preclinical data demonstrating that Telomir-Zn produced dose-dependent survival improvements and reduced hepatic copp…
Immunovant announced positive Week 16 results from its IMVT-1402 trial in difficult-to-treat rheumatoid arthritis, with response rates of 72.7% ACR20, 54.5% ACR50, and 35.8% ACR70.…
Monopar Therapeutics announced publication of Phase 2 study results demonstrating ALXN1840 (tiomolibdate choline) achieved statistically significant reductions in daily copper bala…
Enovis filed a third amendment to its 2020 Omnibus Incentive Plan requesting shareholder approval to increase available shares from approximately 4.3M to 7.97M, effective pending a…
FormFactor filed an amended and restated certificate of incorporation that consolidates existing provisions without material changes to corporate structure or authority. The restat…
Viper Energy, Inc. filed its second amended and restated certificate of incorporation with Delaware, establishing authorized capital of 2.1 billion shares across Class A common, Cl…
Bed Bath & Beyond amended its certificate of incorporation to raise authorized Common Stock from an unspecified prior amount to 200 million shares, with Preferred Stock authorizati…
Lamar Advertising Company filed a proposal to amend and restate its 1996 Equity Incentive Plan, increasing the available share reserve to 19,500,000 shares of Class A Common Stock.…
Medpace Holdings, Inc. filed a restated certificate of incorporation with Delaware, maintaining its authorized capital structure of 250 million common shares and 5 million preferre…
Lipocine announced that Phase 3 clinical data for LPCN 1154, an oral brexanolone candidate for postpartum depression, was accepted for oral and poster presentations at the American…
Relay announced initial Phase 2 data showing zovegalisib achieved a 60% volumetric response rate in PIK3CA-driven vascular anomalies patients at 12 weeks, with 89% investigator-rep…
Pitney Bowes Inc. executed a third amendment to its credit agreement dated May 18, 2026, modifying terms with Bank of America as administrative agent and updating schedules and len…
Driven Brands restated financial results for fiscal 2024-2025 due to corrections in lease accounting, cash, payables, and other items, while reporting FY2025 revenue growth of 6.3%…
Entrada shared a corporate presentation on its ENTR-601-44 candidate in Duchenne muscular dystrophy, outlining expectations for open-label period completion by end-2026 and multipl…
Cullinan Therapeutics announced initial clinical data from two Phase 1 studies of CLN-978, a CD19xCD3 T cell engager, showing favorable safety profile and robust B cell depletion w…
The Federal Reserve Board has approved an application submitted by the Stephen M. Calk 2025 Trust. The specific details and implications of the approval were not disclosed in the a…
The Federal Reserve Board does not object to United Texas Bank of Dallas converting from a Federal Reserve-supervised bank to a national bank supervised by the Office of the Comptr…
The Federal Reserve Board has terminated all enforcement actions against UBS Group AG, Credit Suisse AG, and related entities. This action follows UBS's acquisition of Credit Suiss…
The Federal Reserve Board published findings from two surveys of senior bank financial officers regarding their preferences on discount window operating days and strategies for man…